home / stock / ecor / ecor news


ECOR News and Press, electroCore Inc.

Stock Information

Company Name: electroCore Inc.
Stock Symbol: ECOR
Market: NASDAQ
Website: electrocore.com

Menu

Get ECOR Alerts

News, Short Squeeze, Breakout and More Instantly...

ECOR - electroCore to Participate in the 25th Annual Needham Virtual Healthcare Conference

ROCKAWAY, N.J., April 08, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the Needham Virtual Healthcare Conference taking place virtually on April 15, 2026. Joshua Lev...

ECOR - electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore(TM) nVNS for PTSD

ROCKAWAY, N.J., April 07, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the enrollment of the first eight patients in a clinical study being conducted by Acacia Clinics in collaboration with the Vagus Ner...

ECOR - electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD

ROCKAWAY, N.J., April 01, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new clinical findings in Frontiers in Neuroscience  titled “Adjunctive non-invasive vagus nerve stim...

ECOR - electroCore Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

ROCKAWAY, N.J., March 31, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Seth Abrams will join electroCore, effective April 1, 2026, as the Company’s VP, Sales, a...

ECOR - electroCore Expands Intellectual Property Portfolio

ROCKAWAY, N.J., March 30, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the issuance of two new U.S. patents that further bolster the Company’s already extensive intellectual property portfolio. Th...

ECOR - ElectroCore outlines 30% revenue growth potential for 2026 as leadership transition advances

2026-03-19 20:02:57 ET More on ElectroCore electroCore, Inc. (ECOR) Q4 2025 Earnings Call Transcript electroCore, Inc. (ECOR) Discusses Neuromodulation Platform, Business Evolution, and Strategic Priorities Transcript electroCore expects FY 2025 revenue between $31.8...

ECOR - electroCore, Inc. (ECOR) Q4 2025 Earnings Call Transcript

2026-03-19 20:02:20 ET electroCore, Inc. (ECOR) Q4 2025 Earnings Call March 19, 2026 4:30 PM EDT Company Participants Daniel Goldberger - CEO & Director Thomas Errico - Founder & Independent Chairman Joshua Lev - Chief Financial Officer ... Read t...

ECOR - electroCore (ECOR) Q4 2025 Earnings Transcript

2026-03-19 19:37:00 ET Image source: The Motley Fool. Thursday, March 19, 2026 at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

ECOR - ElectroCore GAAP EPS of -$1.65 beats by $0.07, revenue of $32.02M beats by $0.07M

2026-03-19 16:21:13 ET More on ElectroCore electroCore, Inc. (ECOR) Discusses Neuromodulation Platform, Business Evolution, and Strategic Priorities Transcript electroCore expects FY 2025 revenue between $31.8M and $32M Seeking Alpha’s Quant Rating on ElectroC...

ECOR - electroCore Announces Full Year 2025 Financial Results and Organizational Changes

Record f ull year 2025 net sales of $ 32.0 , an increase of 27% over $25.2 million for the full year 2024 driven by 25% annual growth in our U.S. prescription business and 97% increase in general wellness sales Announces the retirement of Dan Goldberger as Chief Executi...

Next 10